Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Clinical Nuclear Medicine
|
January 24, 2025
High PSMA Avidity, Yet Still Benign: The Importance of CT Morphology for Diagnosing Fibrous Dysplasia on PSMA-Targeted PET/CT
Ryan Reddy, Gary A Ulaner
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|
December 14, 2011
Obstructive parotitis secondary to an acute masseteric bend
Ryan Reddy, David R White, M Boyd Gillespie
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
British Journal of Haematology
|
April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Joshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Clinical Nuclear Medicine
|
January 24, 2025
High PSMA Avidity, Yet Still Benign: The Importance of CT Morphology for Diagnosing Fibrous Dysplasia on PSMA-Targeted PET/CT
Ryan Reddy, Gary A Ulaner
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|
December 14, 2011
Obstructive parotitis secondary to an acute masseteric bend
Ryan Reddy, David R White, M Boyd Gillespie
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
British Journal of Haematology
|
April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Joshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Page
of 1